Works by Rostásy, Kevin


Results: 28
    1
    2
    3

    Investigations on CXCL13 in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

    Published in:
    JAMA Neurology, 2015, v. 72, n. 2, p. 180, doi. 10.1001/jamaneurol.2014.2956
    By:
    • Leypoldt, Frank;
    • Höftberger, Romana;
    • Titulaer, Maarten J.;
    • Armangue, Thais;
    • Gresa-Arribas, Nuria;
    • Jahn, Holger;
    • Rostásy, Kevin;
    • Schlumberger, Wolfgang;
    • Meyer, Thomas;
    • Wandinger, Klaus-Peter;
    • Rosenfeld, Myrna R.;
    • Graus, Francesc;
    • Dalmau, Josep
    Publication type:
    Article
    4
    5

    Rituximab treatment in pediatric‐onset multiple sclerosis.

    Published in:
    European Journal of Neurology, 2024, v. 31, n. 5, p. 1, doi. 10.1111/ene.16228
    By:
    • Breu, Markus;
    • Sandesjö, Fredrik;
    • Milos, Ruxandra‐Iulia;
    • Svoboda, Jan;
    • Salzer, Jonatan;
    • Schneider, Lisa;
    • Reichelt, Julian Benedikt;
    • Bertolini, Annikki;
    • Blaschek, Astrid;
    • Fink, Katharina;
    • Höftberger, Romana;
    • Lycke, Jan;
    • Rostásy, Kevin;
    • Seidl, Rainer;
    • Siegert, Sandy;
    • Wickström, Ronny;
    • Kornek, Barbara
    Publication type:
    Article
    6
    7
    8
    9
    10

    Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.

    Published in:
    Multiple Sclerosis Journal, 2016, v. 22, n. 14, p. 1821, doi. 10.1177/1352458516631038
    By:
    • Baumann, Matthias;
    • Strautmanis, Jurgis;
    • Syrbe, Steffen;
    • Vieker, Silvia;
    • Höftberger, Romana;
    • Rostásy, Kevin;
    • Hennes, Eva-Maria;
    • Schanda, Kathrin;
    • Reindl, Markus;
    • Karenfort, Michael;
    • Kornek, Barbara;
    • Seidl, Rainer;
    • Diepold, Katharina;
    • Lauffer, Heinz;
    • Marquardt, Iris
    Publication type:
    Article
    11

    Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

    Published in:
    Multiple Sclerosis Journal, 2015, v. 21, n. 7, p. 866, doi. 10.1177/1352458514555785
    By:
    • Höftberger, Romana;
    • Sepulveda, María;
    • Armangue, Thaís;
    • Blanco, Yolanda;
    • Rostásy, Kevin;
    • Cobo Calvo, Alvaro;
    • Olascoaga, Javier;
    • Ramió-Torrentà, Lluís;
    • Reindl, Markus;
    • Benito-León, Julián;
    • Casanova, Bonaventura;
    • Arrambide, Georgina;
    • Sabater, Lidia;
    • Graus, Francesc;
    • Dalmau, Josep;
    • Saiz, Albert
    Publication type:
    Article
    12
    13

    Reply to "Investigating the Immunopathogenic Mechanisms Underlying MOGAD".

    Published in:
    Annals of Neurology, 2022, v. 91, n. 2, p. 300, doi. 10.1002/ana.26278
    By:
    • Keller, Christian W.;
    • Lopez, Joseph A.;
    • Wendel, Eva‐Maria;
    • Ramanathan, Sudarshini;
    • Gross, Catharina C.;
    • Klotz, Luisa;
    • Reindl, Markus;
    • Dale, Russell C.;
    • Wiendl, Heinz;
    • Rostásy, Kevin;
    • Brilot, Fabienne;
    • Lünemann, Jan D.
    Publication type:
    Article
    14

    Complement Activation Is a Prominent Feature of MOGAD.

    Published in:
    Annals of Neurology, 2021, v. 90, n. 6, p. 976, doi. 10.1002/ana.26226
    By:
    • Keller, Christian W.;
    • Lopez, Joseph A.;
    • Wendel, Eva‐Maria;
    • Ramanathan, Sudarshini;
    • Gross, Catharina C.;
    • Klotz, Luisa;
    • Reindl, Markus;
    • Dale, Russell C.;
    • Wiendl, Heinz;
    • Rostásy, Kevin;
    • Brilot, Fabienne;
    • Lünemann, Jan D.
    Publication type:
    Article
    15
    16

    Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

    Published in:
    2018
    By:
    • Mueller, Stefanie H.;
    • Färber, Anna;
    • Prüss, Harald;
    • Melzer, Nico;
    • Golombeck, Kristin S.;
    • Kümpfel, Tania;
    • Thaler, Franziska;
    • Elisak, Martin;
    • Lewerenz, Jan;
    • Kaufmann, Max;
    • Sühs, Kurt‐Wolfram;
    • Ringelstein, Marius;
    • Kellinghaus, Christoph;
    • Bien, Christian G.;
    • Kraft, Andrea;
    • Zettl, Uwe K.;
    • Ehrlich, Sven;
    • Handreka, Robert;
    • Rostásy, Kevin;
    • Then Bergh, Florian
    Publication type:
    journal article
    18
    19

    Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy.

    Published in:
    Annals of Clinical & Translational Neurology, 2022, v. 9, n. 9, p. 1437, doi. 10.1002/acn3.51645
    By:
    • Freigang, Maren;
    • Steinacker, Petra;
    • Wurster, Claudia D.;
    • Schreiber-Katz, Olivia;
    • Osmanovic, Alma;
    • Petri, Susanne;
    • Koch, Jan C.;
    • Rostásy, Kevin;
    • Huss, André;
    • Tumani, Hayrettin;
    • Winter, Benedikt;
    • Falkenburger, Björn;
    • Ludolph, Albert C.;
    • Otto, Markus;
    • Hermann, Andreas;
    • Günther, René
    Publication type:
    Article
    20
    21

    Epidemiology of Pediatric NMOSD in Germany and Austria.

    Published in:
    Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00415
    By:
    • Lechner, Christian;
    • Breu, Markus;
    • Wendel, Eva-Maria;
    • Kornek, Barbara;
    • Schanda, Kathrin;
    • Baumann, Matthias;
    • Reindl, Markus;
    • Rostásy, Kevin
    Publication type:
    Article
    22
    23

    Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol

    Published in:
    Orphanet Journal of Rare Diseases, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13023-024-03495-1
    By:
    • Driedger, Jan H.;
    • Schröter, Julian;
    • Hertzberg, Christoph;
    • Weschke, Bernhard;
    • Kaindl, Angela M.;
    • Lücke, Thomas;
    • Thiels, Charlotte;
    • Klotz, Kerstin Alexandra;
    • Fazeli, Walid;
    • Rostásy, Kevin;
    • Wiethoff-Ubrig, Lucia;
    • Kaiser, Olaf;
    • Trollmann, Regina;
    • Mammadova, Dilbar;
    • Schubert-Bast, Susanne;
    • Bach, Alexia;
    • Eckenweiler, Matthias;
    • Schönberger, Jan;
    • Martakis, Kyriakos;
    • Hahn, Andreas
    Publication type:
    Article
    24

    Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol

    Published in:
    Orphanet Journal of Rare Diseases, 2025, v. 20, p. 1, doi. 10.1186/s13023-024-03495-1
    By:
    • Driedger, Jan H.;
    • Schröter, Julian;
    • Hertzberg, Christoph;
    • Weschke, Bernhard;
    • Kaindl, Angela M.;
    • Lücke, Thomas;
    • Thiels, Charlotte;
    • Klotz, Kerstin Alexandra;
    • Fazeli, Walid;
    • Rostásy, Kevin;
    • Wiethoff-Ubrig, Lucia;
    • Kaiser, Olaf;
    • Trollmann, Regina;
    • Mammadova, Dilbar;
    • Schubert-Bast, Susanne;
    • Bach, Alexia;
    • Eckenweiler, Matthias;
    • Schönberger, Jan;
    • Martakis, Kyriakos;
    • Hahn, Andreas
    Publication type:
    Article
    25
    26
    27
    28